Enovis Corp

C520

Company Profile

  • Business description

    Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

  • Contact

    2711 Centerville Road
    Suite 400
    WilmingtonDE19808
    USA

    T: +1 302 252-9160

    E: [email protected]

    https://www.enovis.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2025

    Employees

    7,367

Stocks News & Analysis

stocks

Undervalued ASX retailer benefiting from rebound in spending

Uplift in sales momentum continues.
stocks

Undervalued ASX share searches for cost savings

Cost savings from recent acquisition underpin our earnings growth forecasts.
stocks

Chart of the Week: Where we see opportunities after year end market sell-off

The latest insights from our equity research team.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,983.3028.900.32%
CAC 408,127.5541.790.52%
DAX 4024,339.5544.940.18%
Dow JONES (US)48,704.01646.261.34%
FTSE 1009,709.035.870.06%
HKSE25,976.79446.281.75%
NASDAQ23,593.8660.30-0.25%
Nikkei 22550,836.55687.731.37%
NZX 50 Index13,406.9111.040.08%
S&P 5006,901.0014.320.21%
S&P/ASX 2008,697.3032.400.37%
SSE Composite Index3,889.3516.030.41%

Market Movers